The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension.
Changlei BaoShuxin LiangYing HanZi YangShiyun LiuYanan SunShichuang ZhengYuzhu LiTing WangYali GuKang WuStephen M BlackJian WangSteffan T NawrockiJennifer S CarewJason X-J YuanHaiyang TangPublished in: Hypertension (Dallas, Tex. : 1979) (2022)
These data indicate that ROC-325 is a promising novel agent for the treatment of PH that inhibits autophagy, downregulates HIF levels, and increases nitric oxide production.